Meagan Parrish on Muck Rack

Meagan Parrish

Verified
Wisconsin
As seen in: Industry Dive, PharmaVOICE, Yahoo Finance, Flipboard, Yahoo, Genetic Literacy Project, BioPharma Dive, Manufacturing.net, Food Manufacturing, Manufacturing Business Technology, Pharma Manufacturing, Plant Services and
Senior editor for @industrydive, follower of the pharma world, proud mama, frequent flyer, occasional belly dancer.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Meagan

Contact Meagan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Astellas taps AI to reshape clinical programs as rising stars emerge Original

|
By Meagan Parrish 
| PharmaVOICE
This audio is auto-generated. Please let us know if you have feedback. Astellas Pharma has been on a quest to transform its approach to drug development in the last few years with the goal of ditching its long-held reliance on outsourcing and bringing more operations in-house.
Open in Who Shared View Duplicates (2) Issue with article?

Don't miss the most important voices in pharma Original

|
By Meagan Parrish 
| PharmaVOICE
This audio is auto-generated. Please let us know if you have feedback. Some of the biggest news and trends captured in PharmaVoice’s newsletter this week. Sign up here to receive the newsletter daily. Bristol Myers Squibb is under pressure to make good on its $14 billion acquisition of Karuna Therapeutics, which brought its breakthrough schizophrenia drug Cobenfy into the Big Pharma’s fold.
Open in Who Shared View Duplicates (2) Issue with article?

Don't miss the most important voices in pharma

|
By Meagan Parrish 
| PharmaVOICE
This audio is auto-generated. Please let us know if you have feedback. Orbiting about 250 miles above Earth, the International Space Station has long provided a lab for medical R&D in microgravity. That unique environment also created the breeding ground for one of the industry’s most notable research achievements in space: Merck & Co.’s FDA nod last year for a new formulation of its powerhouse drug Keytruda.
Open in Who Shared Issue with article?
See all 979 articles

Actions

Share this page

Get in touch with Meagan

Contact Meagan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified